Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.

Cochrane database of systematic reviews (Online)

Volumn 12, Issue , 2010, Pages

  Mukundan, Anitha ^a   Faulkner, Guy ^b   Cohn, Tony ^b   Remington, Gary ^b  

^a City Mental Health Team   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE; PIPERAZINE DERIVATIVE; QUETIAPINE; QUINOLONE DERIVATIVE;

BLOOD; BODY MASS; BODY WEIGHT; DIET RESTRICTION; DRUG EFFECT; DRUG SUBSTITUTION; GLUCOSE BLOOD LEVEL; HUMAN; META ANALYSIS; METABOLISM; REVIEW; SCHIZOPHRENIA; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; DIBENZOTHIAZEPINES; DRUG SUBSTITUTION; FASTING; HUMANS; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 79952202288     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)